Colorectal Cancer Mortality Following an Organized Fecal Immunochemical Test-Based Screening Program

Luis Bujanda1,2, Beatriz Val1,2, Isabel Portillo Villares3

  • 1Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute-Donostia University Hospital, University of the Basque Country (UPV/EHU), Donostia-San Sebastián, Spain.

JAMA Network Open
|August 5, 2026
PubMed
Summary

Organized fecal immunochemical testing (FIT) screening significantly reduced colorectal cancer (CRC) mortality by 29.6% in Spain. The program showed particular success in individuals aged 50-69, with a 50.1% decline in CRC deaths.